Sports Performance Drink Makers Get FDA Warning Calling for Recall

Federal health regulators have issued warnings to ten companies that manufacture sports performance drinks, indicating that they are failing to make sure the drinks are safe before marketing them and that they should be removed from the market. 

The FDA sent the warning letters on April 27, to manufacturers of drinks using dimethylamylamine, also known as DMAA.

Companies that received the letters include Exclusive Supplements, Fahrenheit Nutrition, Gaspari Nutrition, iSatori Global Technologies, LLC, Muscle Warfare, Inc., MuscleMeds Performance Technologies, Nutrex Research, SEI Pharmaceuticals, SNI LLC and USP Labs, LLC.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

According to the FDA, DMAA constitutes a new dietary ingredient not marketed in dietary supplements prior to 1994. That means that the companies have to legally notify the FDA of evidence that supports the claims that the ingredient is safe.

The drinks that contain DMAA include:

  • Biorhythm SSIN Juice
  • Lean Efx
  • Spirodex
  • PWR
  • Napalm
  • Code Red
  • Hemo Rage Black
  • Lipo-6 Black
  • MethylHex 4,2
  • Nitric Blast
  • Oxy Elite Pro
  • Jack3D

“Before marketing products containing DMAA, manufacturers and distributors have a responsibility under the law to provide evidence of the safety of their products,” Dr. Daniel Fabricant, director of the FDA’s Dietary Supplement Program said in a press release. “They haven’t done that and that makes the products adulterated.”

According to the FDA, DMAA side effects can include a narrowing of the blood vessels and arteries, and can cause heart attacks, high blood pressure and shortness of breath. The FDA reports that it has received 42 adverse event reports tied to drinks containing DMAA, ranging from heart problems, psychiatric problems and death.

The companies have been ordered to cease sales of the drink immediately and are warned that they could be subject to further enforcement action without warning. They have 15 days to respond to the letters to show that they are addressing the violations.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury (Posted today)

Complaint comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits filed in U.S. District Courts nationwide should be centralized before one judge.

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 4 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.